Medacta Group SA (XSWX:MOVE) Full Year 2024 Earnings Call Highlights: Record Growth and ...

Medacta Group SA (XSWX:MOVE) Full Year 2024 Earnings Call Highlights: Record Growth and ...
Instrument CapEx growth hints at market opportunities, aligning with historical patterns. Positive FX evolution boosts financial income, leading to favorable results. GMK SpheriKA gains approval in Japan, with Australia pending.